Macquarie Group Ltd. bought a new position in shares of Iqvia Holdings Inc (NYSE:IQV) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,605,554 shares of the medical research company’s stock, valued at approximately $157,217,000. Macquarie Group Ltd. owned approximately 0.77% of Iqvia as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also bought and sold shares of IQV. Winslow Evans & Crocker Inc. acquired a new stake in Iqvia in the fourth quarter valued at approximately $123,000. Focused Wealth Management Inc acquired a new stake in Iqvia in the fourth quarter valued at approximately $166,000. Valeo Financial Advisors LLC acquired a new stake in Iqvia in the fourth quarter valued at approximately $170,000. IFP Advisors Inc acquired a new stake in Iqvia in the fourth quarter valued at approximately $200,000. Finally, Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in Iqvia in the fourth quarter valued at approximately $209,000. 92.34% of the stock is owned by hedge funds and other institutional investors.
In related news, Director Michael J. Evanisko sold 816 shares of the firm’s stock in a transaction on Monday, March 5th. The stock was sold at an average price of $100.00, for a total transaction of $81,600.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider James H. Erlinger III sold 10,000 shares of the firm’s stock in a transaction on Wednesday, January 17th. The stock was sold at an average price of $99.97, for a total value of $999,700.00. The disclosure for this sale can be found here. Insiders have sold 21,712 shares of company stock worth $2,176,034 over the last 90 days. 6.00% of the stock is currently owned by company insiders.
Several analysts have issued reports on IQV shares. TheStreet raised shares of Iqvia from a “c+” rating to a “b” rating in a research report on Wednesday, December 13th. SunTrust Banks raised shares of Iqvia from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. ValuEngine raised shares of Iqvia from a “hold” rating to a “buy” rating in a research report on Tuesday, February 20th. Zacks Investment Research raised shares of Iqvia from a “hold” rating to a “buy” rating and set a $112.00 price objective for the company in a research report on Thursday, January 18th. Finally, Royal Bank of Canada set a $118.00 price objective on shares of Iqvia and gave the company a “buy” rating in a research report on Thursday, February 15th. Eight equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. Iqvia has an average rating of “Buy” and an average target price of $110.02.
Iqvia stock opened at $94.85 on Friday. The company has a market cap of $20,166.79, a PE ratio of 21.75, a price-to-earnings-growth ratio of 1.40 and a beta of 0.63. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.19 and a quick ratio of 1.19. Iqvia Holdings Inc has a 52 week low of $78.09 and a 52 week high of $110.67.
Iqvia (NYSE:IQV) last released its earnings results on Wednesday, February 14th. The medical research company reported $1.32 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.34 by ($0.02). Iqvia had a net margin of 13.44% and a return on equity of 13.03%. The business had revenue of $2.16 billion for the quarter, compared to analysts’ expectations of $2.14 billion. During the same quarter last year, the company posted $1.09 earnings per share. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. analysts forecast that Iqvia Holdings Inc will post 5.02 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Macquarie Group Ltd. Buys Shares of 1,605,554 Iqvia Holdings Inc (IQV)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/07/1605554-shares-in-iqvia-holdings-inc-iqv-acquired-by-macquarie-group-ltd.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.